Trials / Unknown
UnknownNCT05003154
Digitalized Management Exploration for Gestational Diabetes Mellitus in China
Comparison of Conventional Mode and Combined Digitalized Mode of Management for Gestational Diabetes Mellitus in China
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Gestational diabetes mellitus (GDM) can lead to adverse perinatal and long-term outcomes, and it is so important to manage this disease in pregnancy. Digitalized managements have been proved economical and effective in some chronic diseases like type II diabetes mellitus. The purpose of the current study was to develop and evaluate a digitalized mode for GDM management using mobile healthcare and some wearable devices. Subjects were randomly divided into a conventional management group and combined digitalized management group after diagnosed with GDM during 24-28 weeks of gestation. The conventional mangement group received conventional GDM management and could freely use the mobile healthcare application. The mobile management group received digitalized healthcare services from artificial intelligence under the supervision of obstetricians, in addition to conventional management. The effectiveness of digitalized management were evaluated mainly through the result values of the labotatory tests related to blood glucose controlling and perinatal outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Digitalized management | In addition to conventional management, Patients also receive digitalized management, which provides personalized guidance in diet, excercise, prenatal visit, blood glucose monitoring,etc., from artificail intelliegence (AI) supevised by obstetricians, through a smartphone application and some werable devices (like sports bracelet). The pivotal AI are based on clinical experience from obstetricians, therapeutic principle from official Guidelines and abundant data in previous work, and it will works under strict supervision. |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2024-01-01
- Completion
- 2024-08-01
- First posted
- 2021-08-12
- Last updated
- 2021-08-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05003154. Inclusion in this directory is not an endorsement.